New Delhi: Global healthcare company Abbott on Monday announced the launch of AVEIR DR, which as per the company is world’s first dual chamber leadless pacemaker system, in India. The next-generation ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

When Abbott reeled in FDA approval for its first leadless pacemaker last spring, it was playing catch-up with Medtronic, whose Micra implant became the first such device greenlighted by the regulator ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...

Single-chamber ventricular leadless pacemakers do not support atrial pacing or consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system consisting of two devices implanted ...

Boston Teacher Shares Life-Changing Experience with Breakthrough Dual Chamber Leadless Pacemaker During Nationwide Interviews in Conjunction with D S Simon Media. NEW YORK, Oct. 30, 2025 (GLOBE ...

The AVEIR dual chamber leadless pacemaker was implanted via the patient's right internal jugular vein (instead of the femoral vein) so the patient could move easily and return to sports sooner. The ...

Big news comes in a very small package for the more than 200,000 Americans who get a pacemaker each year to treat slow or irregular heart rhythms. Last week, the U.S. Food and Drug Administration ...

NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Abbott today announced late-breaking results from the AVEIR™ dual-chamber (DR) i2i™ Investigational Device Exemption (IDE) study, a large-scale study to ...

The Aveir DR dual-chamber leadless pacemaker system (Abbott) performs well out to 1 year in patients largely treated for sinus node dysfunction or atrioventricular (AV) block, according to extended ...

The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company’s implanted Accolade pacemakers, which may need to be replaced earlier ...